Reviewer’s report
Title: 
‘Every medicine is part poison’: A qualitative inquiry into the perceptions
and experiences of choosing contraceptive methods of migrant Chinese women
living in Australia
Version: 
0 
Date: 
06 Mar 2020
Reviewer: 
Agani Afaya
Reviewer's report:
BMC Women's Health
'Every medicine is part poison': A qualitative inquiry into the perceptions and
experiences of choosing contraceptive methods of migrant Chinese women
living in
Australia
The manuscript is well written; I enjoyed reading it, especially 'every medicine is
a part poison' the findings are similar to my certain making me relate well to the
manuscript. It will be interesting to explore Chinese men's view on choosing
contraception for their wife
ABSTRACT
Methods; what was your study design and which theoretical approach was used?
Why not more then years? 
Results: Let the reader know your major themes identified; go straight to your
findings and stop explaining findings
Background
Let the reader understand what contraceptives are? The commonly used
contraceptive methods by women in Australia. 
Decisions about contraceptive methods are preference-sensitive. (provide
reference)
Methods
1. The methods seem confusing and not clear; Use the Consolidated criteria for
reporting qualitative studies (COREQ): 32-item checklist to guide your methods
(restructure)
2. Describe your study setting
3. I have missed reflexivity in this study: say something on reflexivity 
4. Design; which design did you use and what theoretical approach was adopted?
Is it Interpretative, constructionist, feminist, critical, participative?
"We obtained ethics approval from the University of Sydney human research
ethics committee [ref: 2018/159] and Family Planning New South Wales (NSW)
Project Ethical Risk Team (PERT) [ref: PERT 25]". Remove this from study
design and move to ethical consideration subheading
5. Make sure you first of all define all abbreviations in the text before using it
subsequently. 
6. data collection (interviews): come out clear on how you conducted the
interviews. 
7. How many interviews were completed by phone and how many interviews
were face to face 
8. HD translated two additional Chinese transcripts into English for the view of
other non-Chinese speaking team members. Why only two but not all? Who is
HD/what is HD? The reader shouldn't be struggling to understand what you are
trying to say, be clear in your first instance and subsequently abbreviation can be
used. Eg HD (first author)
9. Data analysis: this is too lengthy: summarize and also include your coding tree
as an appendix
Include 
1. Trustworthiness: how did you ensure methodological rigour? 
2. Ethical consideration 
Results: 
1. Delete Chinese characters; repetition
2. Make sure you narrate before the participants' quotes. Do not quote before you
narrate participants view point. Eg. 'For above participant, having monthly
periods was seen as a sign of female fertility and womanhood. Her views on the
link between fertility and menstruation were echoed by other participants'.
Are the methods appropriate and well described?
If not, please specify what is required in your comments to the authors.
No
Does the work include the necessary controls?
If not, please specify which controls are required in your comments to the
authors.
Yes
Are the conclusions drawn adequately supported by the data shown?
If not, please explain in your comments to the authors.
Yes
Are you able to assess any statistics in the manuscript or would you
recommend an additional statistical review?
If an additional statistical review is recommended, please specify what aspects
require further assessment in your comments to the editors.
Not relevant to this manuscript
Quality of written English
Please indicate the quality of language in the manuscript:
Needs some language corrections before being published
Declaration of competing interests
Please complete a declaration of competing interests, considering the following
questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or
salary from an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way
gain or lose financially from the publication of this manuscript, either now
or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the
content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents relating to the content of
the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this
paper?
If you can answer no to all of the above, write 'I declare that I have no competing
interests' below. If your reply is yes to any, please give details below.
I declare that I have no competing interests
I agree to the open peer review policy of the journal. I understand that my name
will be included on my report to the authors and, if the manuscript is accepted
for publication, my named report including any attachments I upload will be
posted on the website along with the authors' responses. I agree for my report to
be made available under an Open Access Creative Commons CC-BY license
(
http://creativecommons.org/licenses/by/4.0/
). I understand that any comments
which I do not wish to be included in my named report can be included as
confidential comments to the editors, which will not be published.
I agree to the open peer review policy of the journal